TriSalus Life Sciences, Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $46.3M | $56.6M | $20.4M | $22.7M | $26.5M | $13.0M | $8.5M | $11.3M |
| Accounts Receivable | $6.5M | $5.2M | $6.6M | $5.0M | $5.6M | $5.5M | $5.1M | $4.9M |
| Inventory | $4.2M | $3.8M | $3.1M | $3.3M | $3.8M | $4.2M | $4.0M | $4.0M |
| Total Current Assets | $59.7M | $68.1M | $32.2M | $33.3M | $38.1M | $25.1M | $20.7M | $23.8M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | $1.8M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $62.4M | $71.0M | $35.3M | $36.5M | $41.3M | $28.6M | $24.0M | $27.5M |
| Liabilities | ||||||||
| Accounts Payable | $3.8M | $4.2M | $3.0M | $3.8M | $1.9M | $2.8M | $2.3M | $1.4M |
| Total Current Liabilities | $11.2M | $11.8M | $11.5M | $10.9M | $9.3M | $11.8M | $10.2M | $9.9M |
| Long-Term Debt | $33.1M | $33.1M | $33.0M | $32.8M | $32.3M | $31.7M | $22.1M | $21.7M |
| Total Liabilities | $55.9M | $58.2M | $69.2M | $63.2M | $60.7M | $63.0M | $49.9M | $47.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-338.2M | $-329.0M | $-330.6M | $-321.0M | $-298.2M | $-289.9M | $-279.5M | $-269.4M |
| Total Stockholders' Equity | $6.6M | $12.8M | $-33.9M | $-26.7M | $-19.4M | $-34.4M | $-25.9M | $-20.4M |